We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Allergy and Immunology

Samuel C. Bukantz, MD; Richard F. Lockey, MD
JAMA. 1990;263(19):2623-2625. doi:10.1001/jama.1990.03440190079041.
Text Size: A A A
Published online


The exploration of immunologic mechanisms has entered a new phase, that of molecular biology,1 resulting in an improved understanding of diseases that arise from immunologic injury. From among the many basic and clinical contributions, Science has selected a "Molecule of the Year," the DNA polymerase, which drives the polymerase chain reaction.2

The polymerase chain reaction has been used to detect proviral DNA in the peripheral blood mononuclear cells of persons infected with human immunodeficiency virus 1 who are seropositive and virus culture negative. An assay has also been developed to detect human immunodeficiency virus 1 RNA in patients with acquired immunodeficiency syndrome and acquired immunodeficiency syndrome—related complex, which raises the possibility of early detection of human immunodeficiency virus in plasma and serum through gene amplification,3 of obvious benefit in blood bank screening.

The long-term safety and efficacy of zidovudine therapy have been examined in 229 subjects with


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.